Accessibility helpSkip to navigationSkip to contentSkip to footer

Cookies on FT Sites

We use cookies and other data for a number of reasons, such as keeping FT Sites reliable and secure, personalising content and ads, providing social media features and to analyse how our Sites are used.

Accept cookies
Manage cookies
  • Sign In
  • Subscribe
Open side navigation menuOpen search bar
Financial Times
SubscribeSign InmyFT
  • Home
  • World
    Sections
    • World Home
    • Global Economy
    • UK
    • US
    • China
    • Africa
    • Asia Pacific
    • Emerging Markets
    • Europe
    • War in Ukraine
    • Americas
    • Middle East & North Africa
    • Australia & NZ
    Most Read
    • Israel protests intensify after Netanyahu sacks defence minister
    • Vladimir Putin plans to deploy tactical nuclear weapons in Belarus
    • Russia embraces China’s renminbi in face of western sanctions
    • IMF chief warns of increased risks to financial stability
    • Israel plunges into political turmoil over Netanyahu’s judicial reforms
  • US
    Sections
    • US Home
    • US Economy
    • US Companies
    • US Politics & Policy
    Most Read
    • Companies
      Sections
      • Companies Home
      • Banks in turmoil
      • Energy
      • Financials
      • Health
      • Industrials
      • Media
      • Professional Services
      • Retail & Consumer
      • Tech Sector
      • Telecoms
      • Transport
      Most Read
      • European ammunition maker says plant expansion hit by energy-guzzling TikTok site
      • Air India boss hails biggest turnround effort in airline’s history
      • First Citizens to buy failed Silicon Valley Bank
      • Northvolt in talks to secure $5bn to become Europe’s biggest battery maker
      • Wine growers fear funding will wither after fall of Silicon Valley Bank
    • Tech
    • Markets
      Sections
      • Markets Home
      • Alphaville
      • Markets Data
      • Cryptofinance
      • Capital Markets
      • Commodities
      • Currencies
      • Equities
      • Fund Management
      • Trading
      • Moral Money
      • ETF Hub
      Most Read
      • Money market funds swell by more than $286bn as investors pull deposits from banks
      • Live news: Israel’s Ben Gurion airport grounds flights amid protests
      • Russia embraces China’s renminbi in face of western sanctions
      • Jay Powell and Janet Yellen struggle to calm nerves in banking crisis
      • City braces for tighter regulation after banking turmoil
    • Climate
    • Opinion
      Sections
      • Opinion Home
      • Columnists
      • The FT View
      • Lex
      • Obituaries
      • Letters
      Most Read
      • Why five days in the office don’t add up
      • Credit Suisse’s demise: a new twist on the ‘Swiss finish’
      • The unstoppable rise of government rescues
      • A new technology boom is at hand
      • Japan remains free from the tyranny of tipping
    • Work & Careers
      Sections
      • Work & Careers Home
      • Business School Rankings
      • Business Education
      • Entrepreneurship
      • Recruitment
      • Business Books
      • Business Travel
      Most Read
      • Matthew Desmond: ‘America does so much more to subsidise affluence than alleviate poverty’
      • Culture clash: the challenge of uniting fierce rivals UBS and Credit Suisse
    • Life & Arts
      Sections
      • Life & Arts Home
      • Arts
      • Books
      • Food & Drink
      • FT Magazine
      • House & Home
      • Style
      • Travel
      • FT Globetrotter
      Most Read
      • Everything I, an Italian, thought I knew about Italian food is wrong
      • Is France on the road to a Sixth Republic?
      • Perfectly peaceful Puglian retreats
      • To Istanbul, by train
      • My liquid investigation into Italy’s love affair with Tennent’s Extra
    • HTSI
    MenuSearch
    • Home
    • World
    • US
    • Companies
    • Tech
    • Markets
    • Climate
    • Opinion
    • Work & Careers
    • Life & Arts
    • HTSI
    Financial Times
    SubscribeSign In

    Medical science

    Add to myFT Digest

    Add this topic to your myFT Digest for news straight to your inbox

    • Monday, 27 March, 2023
      BioNTech
      BioNTech forecasts slump in revenues as demand for Covid jab wanes

      Expected fall highlights challenges for pharmaceutical companies that experienced pandemic windfall

      new
    • Friday, 24 March, 2023
      The best books of the week
      Virtual You — how digital doppelgängers could help us lead a healthy life

      An analysis of the potential of technology to transform personalised medicine is both stimulating and comprehensive

    • Thursday, 23 March, 2023
      Disease control and prevention
      WHO warns over spread of Marburg virus after Tanzania deaths

      Global health body urges increased vigilance to reduce transmission of deadly disease

    • Wednesday, 22 March, 2023
      Drugs research
      Novartis scraps drug trial in blow to UK life sciences ambitions

      Swiss group rethinks NHS collaboration after low take-up of treatment during rollout via GPs

    • Friday, 17 March, 2023
      Coronavirus pandemic
      WHO urges China to share more data on possible Covid link to raccoon dogs

      Health body says genetic sequences are not definitive and all origin theories, including lab leak, remain on table

    • Wednesday, 15 March, 2023
      High sucralose doses suppress immune system, research on mice shows

      Unexpected finding suggests popular sweetener could treat autoimmune conditions such as arthritis and diabetes

    • Tuesday, 14 March, 2023
      Pharmaceuticals sector
      US clinic offers ketamine therapy to treat alcoholism

      UK biotech Awakn licences ‘party drug’ to addiction clinics

    • Saturday, 11 March, 2023
      Coronavirus pandemic
      Vaccine inequality blamed for boosting global Covid death toll

      Unequal access to jabs in 2021 led to one preventable death every 24 seconds, politicians and activists say

    • Wednesday, 8 March, 2023
      Genomics
      Cost of gene treatments for once incurable diseases too high, scientists warn

      Therapies based on editing of human genomes predicted to have a price tag of $2mn per patient

    • Wednesday, 8 March, 2023
      UK politics & policy
      Chinese genomics company accused of hack attempts by UK minister

      Government later says no ‘evidence’ of attempted hacking of NHS genetic data centre by BGI

    • Saturday, 4 March, 2023
      Thomas Hale
      As China’s politicians gather, the ghosts of zero-Covid live on

      The country dismantled its precautionary measures as quickly as they sprang up — but not at the National People’s Congress

    • Friday, 3 March, 2023
      Plastic pollution
      Plastic ingestion by humans and animals altering cells, scientists say

      Study identifies new stomach disease in seabirds caused by microplastics

    • Friday, 3 March, 2023
      Healthcare
      US health and science bodies unite to fight misinformation ‘infodemic’

      Fifty organisations form coalition to counter dangerous falsehoods and rebuild trust in science

    • Wednesday, 1 March, 2023
      Edward Luce
      America and the China lab leak theory

      The new cold war makes another pandemic more likely

    • Tuesday, 28 February, 2023
      Science
      Scientists target ‘biocomputing’ breakthrough with use of human brain cells

      Proposal for ‘intelligence in a dish’ that can efficiently perform advanced tasks raises ethical concerns

    • Tuesday, 21 February, 2023
      Explainer
      How likely is a human bird flu pandemic?

      Scientists urge more vigorous action to reduce circulation of highly contagious H5N1 strain

    • Wednesday, 15 February, 2023
      Covid-19 vaccines
      CanSino says vaccine demand down after China’s mass Covid infections

      Pharma group hopes for approval of mRNA vaccine for booster shots

    • Sunday, 12 February, 2023
      Pharmaceuticals sector
      Women’s health ‘missing out’ because of male-dominated investment

      Pharma chief says sector is seen as ‘niche’ and leaves women suffering from healthcare inequality

    • Wednesday, 8 February, 2023
      Special ReportFT Health: Future of Antibiotics
      Spread of antibiotic resistance revives interest in bacteria-killing viruses

      Experts believe bacteriophages could be crucial extra tool

    • Friday, 3 February, 2023
      First heart patients diagnosed using new fibre optic technology

      Researchers say device developed in London could help thousands suffering from vascular disease

    • Thursday, 2 February, 2023
      Neural implants in rats pave way to treat brain injuries

      Neuroscience breakthrough demonstrates ability of human organoids to adopt functions of host’s visual cortex

    • Sunday, 29 January, 2023
      Drugs research
      RQ Bio partners with AstraZeneca in Covid antibody fight

      UK biotech racing to keep antibody up to date with latest variants

    • Tuesday, 24 January, 2023
      Kate Bingham
      Britain is losing its chance to become a life sciences superpower

      Short-termism and suspicion in parts of government risk our valuable future in precision medicine

    • Tuesday, 17 January, 2023
      InterviewJenny Harries
      Covid will ‘taunt us’ for years, says UK health security chief

      Future of pandemic less predictable than at the outset because of new variants, says Jenny Harries

    • Wednesday, 11 January, 2023
      Anjana Ahuja
      New Alzheimer’s drug straddles uneasy gulf between help and harm

      For all its landmark status, lecanemab may end up representing a triumph of hope over evidence

    Previous page You are on page 1 Next page

    Useful links

    Support

    View Site TipsHelp CentreContact UsAbout UsAccessibilitymyFT TourCareers

    Legal & Privacy

    Terms & ConditionsPrivacy PolicyCookiesCopyrightSlavery Statement & Policies

    Services

    Share News Tips SecurelyIndividual SubscriptionsGroup SubscriptionsRepublishingExecutive Job SearchAdvertise with the FTFollow the FT on TwitterFT ChannelsSecondary Schools

    Tools

    PortfolioToday's Newspaper (ePaper)Alerts HubBusiness School RankingsEnterprise ToolsNews feedNewslettersCurrency Converter

    Community & Events

    FT CommunityFT Live EventsFT ForumsFT Board DirectorBoard Director Programme

    More from the FT Group

    Markets data delayed by at least 15 minutes. © THE FINANCIAL TIMES LTD 2023. FT and ‘Financial Times’ are trademarks of The Financial Times Ltd.
    The Financial Times and its journalism are subject to a self-regulation regime under the FT Editorial Code of Practice.
    Financial Times

    International Edition

    Subscribe for full access
    • Switch to UK Edition

    Top sections

    • Home
    • World
      • Global Economy
      • UK
      • US
      • China
      • Africa
      • Asia Pacific
      • Emerging Markets
      • Europe
      • War in Ukraine
      • Americas
      • Middle East & North Africa
      • Australia & NZ
    • US
      • US Economy
      • US Companies
      • US Politics & Policy
    • Companies
      • Banks in turmoil
      • Energy
      • Financials
      • Health
      • Industrials
      • Media
      • Professional Services
      • Retail & Consumer
      • Tech Sector
      • Telecoms
      • Transport
    • Tech
    • Markets
      • Alphaville
      • Markets Data
      • Cryptofinance
      • Capital Markets
      • Commodities
      • Currencies
      • Equities
      • Fund Management
      • Trading
      • Moral Money
      • ETF Hub
    • Climate
    • Opinion
      • Columnists
      • The FT View
      • Lex
      • Obituaries
      • Letters
    • Work & Careers
      • Business School Rankings
      • Business Education
      • Entrepreneurship
      • Recruitment
      • Business Books
      • Business Travel
    • Life & Arts
      • Arts
      • Books
      • Food & Drink
      • FT Magazine
      • House & Home
      • Style
      • Travel
      • FT Globetrotter
    • Personal Finance
      • Property & Mortgages
      • Investments
      • Pensions
      • Tax
      • Banking & Savings
      • Advice & Comment
      • Next Act
    • HTSI
    • Special Reports

    FT recommends

    • Lex
    • Alphaville
    • Lunch with the FT
    • FT Globetrotter
    • #techAsia
    • Moral Money
    • FTfm
    • Newsletters
    • Video
    • Podcasts
    • News feed
    • FT Live Events
    • FT Forums
    • Board Director Programme
    • myFT
    • Portfolio
    • Today's Newspaper (ePaper)
    • Crossword
    • Our Apps
    • Help Centre
    • Subscribe
    • Sign In